SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 17.42 |
| Enterprise Value ($M) | 35.56 |
| Book Value ($M) | -9.97 |
| Book Value / Share | -0.22 |
| Price / Book | -1.75 |
| NCAV ($M) | -34.43 |
| NCAV / Share | -0.77 |
| Price / NCAV | -0.51 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -4.07 |
| Return on Assets (ROA) | -1.31 |
| Return on Equity (ROE) | -2.77 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.09 |
| Current Ratio | 0.09 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.09 |
| Assets | 26.56 |
| Liabilities | 36.53 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Wong Hing C | 36.04 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 15,918 | 125,400 | 12.69 | |
| 103,085 | 256,483 | 40.19 | |
| 15,393 | 221,191 | 6.96 | |
| 77,694 | 241,174 | 32.21 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FULC – Fulcrum Therapeutics, Inc. | GANX – Gain Therapeutics, Inc. |
| GHRS – GH Research PLC | HRMY – Harmony Biosciences Holdings, Inc. |
| HROW – Harrow, Inc. |
Financial data and stock pages provided by
Fintel.io